BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database.
<h4>Background</h4>Weight loss, hyperglycaemia and diabetes are known features of pancreatic cancer. We quantified the timing and the amount of changes in body mass index (BMI) and glycated haemoglobin (HbA1c), and their association with pancreatic cancer from five years before diagnosis...
Main Authors: | Agnieszka Lemanska, Claire A Price, Nathan Jeffreys, Rachel Byford, Hajira Dambha-Miller, Xuejuan Fan, William Hinton, Sophie Otter, Rebecca Rice, Ali Stunt, Martin B Whyte, Sara Faithfull, Simon de Lusignan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0275369 |
Similar Items
-
BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database
by: Agnieszka Lemanska, et al.
Published: (2022-01-01) -
BMI and HbA1c are metabolic markers for pancreatic cancer: matched case-control study using a UK primary care database
by: Lemanska, A, et al.
Published: (2022) -
Postal methods for monitoring HbA1c in diabetes mellitus: a protocol for systematic review
by: Jack Colley, et al.
Published: (2022-12-01) -
Using Primary Care Data to Report Real-World Pancreatic Cancer Survival and Symptomatology.
by: Jeffreys, N, et al.
Published: (2021) -
What are the HbA(1c) thresholds for initiating insulin therapy in people with type 2 diabetes in UK primary care?
by: Hinton, W, et al.
Published: (2016)